Cheree H Johnson
Insider
First SEC filing: Jan. 13, 2023 · Latest: Jan. 13, 2023
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 1, 2025 | SPXC | F | 396 | $167.68 | $66,401 | 7,147 Direct | -5.25% | Disposed | 5.4% (price as of 2026-10-05) |
| March 3, 2025 | SPXC | A | 3,414 | · | · | 7,543 Direct | +82.68% | Acquired | (price as of 2026-10-05) |
| March 3, 2025 | SPXC | A | 2,576 | · | · | 2,576 Direct | · | Acquired | (price as of 2026-10-05) |
| July 1, 2024 | SPXC | A | 4,129 | · | · | 4,129 Direct | · | Acquired | (price as of 2026-10-05) |
| July 1, 2024 | SPXC | A | 5,286 | · | · | 5,286 Direct | · | Acquired | (price as of 2026-10-05) |
| Jan. 13, 2023 | XRAY | A | 291 | · | · | 83,059 Direct | +0.35% | Acquired | (price as of 2026-10-05) |
| Nov. 16, 2022 | XRAY | F | 7,893 | $30.60 | $241,526 | 82,584 Direct | -8.72% | Disposed | -72.0% (price as of 2026-10-05) |
| Nov. 16, 2022 | XRAY | A | 65,359 | · | · | 90,477 Direct | +260.21% | Acquired | (price as of 2026-10-05) |
| Oct. 14, 2022 | XRAY | A | 110 | · | · | 25,118 Direct | +0.44% | Acquired | (price as of 2026-10-05) |
| July 8, 2022 | XRAY | A | 85 | · | · | 25,007 Direct | +0.34% | Acquired | (price as of 2026-10-05) |
| April 8, 2022 | XRAY | A | 63 | · | · | 24,923 Direct | +0.25% | Acquired | (price as of 2026-10-05) |
| March 4, 2022 | XRAY | A | 21,200 | · | · | 21,200 Direct | · | Acquired | (price as of 2026-10-05) |
| March 4, 2022 | XRAY | A | 18,762 | · | · | 24,860 Direct | +307.67% | Acquired | (price as of 2026-10-05) |
| March 4, 2022 | XRAY | A | 6,098 | · | · | 6,098 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 3, 2025 | SPXC | Employee stock option to purchase common stock | Common Stock | $138.60 | March 3, 2035 | 2,576 | Acquired |
| July 1, 2024 | SPXC | Employee stock option to purchase common stock | Common Stock | $139.19 | July 1, 2034 | 5,286 | Acquired |
| March 4, 2022 | XRAY | Stock Option (Right to Buy) | Common Stock | $53.30 | March 4, 2032 | 21,200 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).